Background-This study was designed to investigate the contribution of
inhaled salbutamol to the increase in resting metabolic rate found in
patients with chronic airflow limitation who were receiving bronchodil
ator therapy. Methods-The resting metabolic rate of 10 normal subjects
(age 20-47 years, weight 42-105 kg, seven men) was studied after inha
lations of salbutamol or placebo. An open canopy method of indirect ca
lorimetry was used to measure resting oxygen consumption (VO2) and res
ting carbon dioxide production (VCO2). Subjects inhaled two, four, eig
ht, or 12 puffs (100 mug/puff) of salbutamol or placebo in a double bl
ind manner. Recordings of VO2 and VCO2 were made after inhalation of t
he four doses of salbutamol or placebo, integrated over one hour, and
compared. Results-VO2 and VCO2 increased in a dose dependent manner af
ter inhaled salbutamol with a maximum effect at five minutes after inh
alation. After four puffs, VO2 was 203 and 188 ml/kg/h for salbutamol
and placebo respectively. After eight puffs VO2 was 207 and 185 and Vc
o, was 167 and 155 ml/kg/h. After 12 puffs, VO2 was 220 and 190 with a
VCO2 of 181 and 168 ml/kg/h. Twelve puffs of salbutamol increased the
mean (SE) respiratory quotient from 0.85 (0.01) to 0.93 (0.04) at fiv
e minutes indicating an increase in ventilation in excess of metabolic
demand. Mean heart rate increased in parallel with VO2. Conclusion-In
haled salbutamol significantly increases resting metabolic rate in a d
ose dependent manner.